Medicine and Dentistry
Patient
100%
Therapeutic Procedure
57%
Radiation Therapy
48%
Follicular Lymphoma
48%
Fluorodeoxyglucose F 18
29%
Diffuse Large B-Cell Lymphoma
27%
Lymphoma
27%
Niraparib
24%
Computed Tomography
24%
Bone Density
24%
Computer Assisted Tomography
24%
Positron Emission Tomography
24%
Bevacizumab
24%
Platinum
24%
Venous Thromboembolism
24%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
24%
Recurrent Ovarian Cancer
24%
Radiation Oncology
24%
Survival
24%
Patient with Cancer
24%
Chemotherapy
24%
Follow up
21%
Recurrent Disease
16%
Overall Survival
16%
Diseases
15%
Hazard Ratio
12%
Malignant Neoplasm
12%
Death
10%
Cancer Types
9%
Kaplan Meier Method
8%
Age
8%
Analysis
8%
Relapse
8%
Inpatient
8%
Progression Free Survival
6%
Anticoagulation
6%
Cumulative Incidence
6%
Risk Assessment
6%
Retrospective Study
5%
Positron Emission Tomography-Computed Tomography
5%
Systemic Therapy
5%
Biopsy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
48%
Bevacizumab
24%
Platinum
24%
Malignant Neoplasm
24%
Vein Thrombosis
24%
Cohort Study
24%
Ovary Cancer
24%
Chemotherapy
17%
Death
10%
Incidence
10%
Blood Clotting Factor 5 Leiden
8%
Progression Free Survival
6%
Biochemistry, Genetics and Molecular Biology
Computer Assisted Tomography
24%
Single-Nucleotide Polymorphism
24%
Positron Emission Tomography
24%
Radiation
24%
Single Nucleotide Polymorphism
16%
FGG
16%
Computed Tomography
16%
Genotype
8%
Mutation
8%
Nested Gene
8%
Retrospective Study
8%
Genotyping
8%
Allele
8%
Age
8%
Overall Survival
8%
Factor V Leiden
8%
Adjustment
8%
Dose
8%